Sustained release formulation and dosing schedules of...

Details Sustained release formulation and dosing schedules of... Sustained release formulation and dosing schedules of...

A - Human Necessities

61

K

A61K 31/472 (2006.01) A61K 9/20 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2605674

The invention relates to improved materials and methods for therapy to inhibit production of leukotrienes, and all therapeutic applications thereof.

L'invention concerne des produits améliorés et des procédés thérapeutiques d'inhibition de la production de leukotriènes, et toutes les applications thérapeutiques de ceux-ci.

Affiliated with

Also associated with

Rating

Sustained release formulation and dosing schedules of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release formulation and dosing schedules of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release formulation and dosing schedules of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1712259